Beat-to-beat Variability in Persistent Atrial Fibrillation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

32 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-11-30

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Heart rate variability (HRV) in patients with atrial fibrillation (AF) is hardly studied. Though a reduced HRV in patients with heart failure and reduced ejection fraction (HFrEF) has been associated with poor prognosis. Data on HRV in AF-patients without a reduced ejection fraction is lacking. We hypothesize that those patients with persistent atrial fibrillation and larger beat-to-beat variability would be more symptomatic than does those with smaller HRV. To asses this theory we intend to perform a prospective observational trial. Symptoms of Atrial fibrillation will be assessed using Quality of Life questionnaires and 6 minutes walking test. Heart rate variability will be assessed using 24 hour Holter ECG monitoring.

The correlation between symptoms and heart rate variability will be then assessed.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Reasons for Variations in Health Related Quality of Life and Symptom Burden in Patients With Atrial Fibrillation

NCT01553045

Arrhythmias, Cardiac Heart Failure, Systolic Atrial Fibrillation

UNKNOWN

Atrial Fibrillation/Sinus Rhythm Before and After Cardioversion

NCT01779674

Atrial Fibrillation

COMPLETED

Atrial Fibrillation: Chronic Beta-blocker Use Versus As-needed Rate Control Guided by Implantable Cardiac Monitor

NCT05745337

Atrial Fibrillation Diastolic Dysfunction HFpEF - Heart Failure With Preserved Ejection Fraction

RECRUITING PHASE1

Studies of Disorders and Mechanisms Related to Atrial Fibrillation Before and After DC-Conversion.

NCT00429884

Atrial Fibrillation

UNKNOWN

SmartWATCHes for Detection of Atrial Fibrillation

NCT02956343

Atrial Fibrillation

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Persistent Atrial Fibrillation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Persistent atrial fibrillation
* No previous ablation for atrial fibrillation
* At least 18 years old
* Signed written patient's informed consent

Exclusion Criteria

* Paroxysmal atrial fibrillation
* Previous ablation therapy for atrial fibrillation
* Reduced left ventricular ejection fraction (LVEF\<35%)
* Permanent ventricular pacing (including cardiac resynchronization therapy CRT)
* Acute coronary syndrome (ACS) during past 6 weeks.
* Stroke or TIA within past 6 weeks.
* Cardiac surgical operation/ intervention within past 3 months.
* Acute decompensated heart failure
* Treatment with IV Inotropic medications (e.g. Dobutamine, Levosimendan)
* Mitral valve replacement or rheumatic mitral valve stenosis
* Neurological or psychological disease that may impair patient's judgement or compliance
* Pregnancy or Breast-feeding women.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No